Doctor and Pharmacy Shopping for Controlled Substances

Background:Prescription drug abuse is a major health concern nationwide, with West Virginia having one of the highest prescription drug death rates in the United States. Studies are lacking that compare living subjects with persons who died from drug overdose for evidence of doctor and pharmacy shopping for controlled substances. The study objectives were to compare deceased and living subjects in West Virginia for evidence of prior doctor and pharmacy shopping for controlled substances and to identify factors associated with drug-related death. Methods:A secondary data study was conducted using controlled substance, Schedule II–IV, prescription data from the West Virginia Controlled Substance Monitoring Program and drug-related death data compiled by the Forensic Drug Database between July 2005 and December 2007. A case-control design compared deceased subjects 18 years and older whose death was drug related with living subjects for prior doctor and pharmacy shopping. Logistic regression identified factors related to the odds of drug-related death. Results:A significantly greater proportion of deceased subjects were doctor shoppers (25.21% vs. 3.58%) and pharmacy shoppers (17.48% vs. 1.30%) than living subjects. Approximately 20.23% of doctor shoppers were also pharmacy shoppers, and 55.60% of pharmacy shoppers were doctor shoppers. Younger age, greater number of prescriptions dispensed, exposure to opioids and benzodiazepines, and doctor and pharmacy shopping were factors with greater odds of drug-related death. Conclusions:Doctor and pharmacy shopping involving controlled substances were identified, and shopping behavior was associated with drug-related death. Prescription monitoring programs may be useful in identifying potential shoppers at the point of care.

[1]  W. McAllister,et al.  Keeping the lid on: a century of drug regulation and control. , 2003, Drug and alcohol dependence.

[2]  Brady T West,et al.  Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. , 2008, Addictive behaviors.

[3]  R. Klienschmidt,et al.  Doctor shopping. , 1995, Australian family physician.

[4]  A. Gilson,et al.  Drug crime is a source of abused pain medications in the United States. , 2005, Journal of pain and symptom management.

[5]  J. Rehm,et al.  Changes in illicit opioid use profiles across Canada , 2006 .

[6]  Benedikt Fischer,et al.  Changes in illicit opioid use across Canada , 2006, Canadian Medical Association Journal.

[7]  Meelee Kim,et al.  Usefulness of prescription monitoring programs for surveillance—analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006 , 2010, Pharmacoepidemiology and drug safety.

[8]  Leonard J Paulozzi,et al.  Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.

[9]  M. Abrahamowicz,et al.  Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[10]  L. Manchikanti,et al.  National All Schedules Prescription Electronic Reporting Act (NASPER): balancing substance abuse and medical necessity. , 2002, Pain physician.

[11]  W. Hurwitz.  The challenge of prescription drug misuse: a review and commentary. , 2005, Pain medicine.

[12]  B. Kuehn.  Opioid prescriptions soar: increase in legitimate use as well as abuse. , 2007, JAMA.

[13]  Gail K. Strickler,et al.  Risk factors associated with problem use of prescription drugs. , 2004, American Journal of Public Health.

[14]  M. Valenstein,et al.  Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths , 2012 .

[15]  J. Micallef,et al.  Assessment of doctor‐shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database , 2004, Pharmacoepidemiology and drug safety.

[16]  L. Manchikanti,et al.  Evaluation of variables in illicit drug use: does a controlled substance abuse screening tool identify illicit drug use? , 2004, Pain physician.

[17]  B. Kuehn.  Opioid Prescriptions Soar , 2007 .

[18]  Kirsten A Barrett,et al.  Physician Perspectives on a Pilot Prescription Monitoring Program , 2005, Journal of pain & palliative care pharmacotherapy.

[19]  Leonard J. Paulozzi,et al.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.

[20]  A. Paraponaris,et al.  French General Practitioners' Attitudes and Prescription Patterns Toward Buprenorphine Maintenance Treatment , 2005, Journal of addictive diseases.

[21]  S. Fishman,et al.  An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program , 2011, Pharmacoepidemiology and drug safety.

[22]  A. Egberts,et al.  Prevalence and determinants of pharmacy shopping behaviour , 2008, Journal of clinical pharmacy and therapeutics.

[23]  Brady T. West,et al.  Trends and college-level characteristics associated with the non-medical use of prescription drugs among US college students from 1993 to 2001. , 2007, Addiction.

[24]  D. Clode,et al.  Seeking drugs or seeking help? Escalating “doctor shopping” by young heroin users before fatal overdose , 2004, The Medical journal of Australia.

[25]  T. Gomes,et al.  Opioid dose and drug-related mortality in patients with nonmalignant pain. , 2011, Archives of internal medicine.

[26]  J. Inciardi,et al.  Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. , 2007, Pain medicine.

[27]  Yongli Xi,et al.  Increasing deaths from opioid analgesics in the United States , 2006, Pharmacoepidemiology and drug safety.

[28]  Leonard J. Paulozzi,et al.  Vital Signs: Overdoses of Prescription Opioid Pain Relievers and Other Drugs Among Women — United States, 1999–2010 , 2013, MMWR. Morbidity and mortality weekly report.

[29]  J. L. Dahl,et al.  Trends in medical use and abuse of opioid analgesics. , 2000, JAMA.